Pharmacological treatment of Tourette syndrome

被引:16
|
作者
Gilbert, Donald L. [1 ]
Jankovic, Joseph [2 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
关键词
Attention deficit; Hyperactivity; Obsessive-ompulsive; Tics; Tourette; DEEP-BRAIN-STIMULATION; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED TRIAL; PARENT RATING-SCALE; QUALITY-OF-LIFE; DOUBLE-BLIND; TARDIVE-DYSKINESIA; CLINICAL-TRIAL; TIC SEVERITY; CERVICAL MYELOPATHY;
D O I
10.1016/j.jocrd.2014.04.006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Tourette syndrome (TS) is a highly heritable yet heterogeneous childhood onset disorder. The cardinal movement disorder required for diagnosis is tics. As persons with tics or TS often have obsessive/compulsiveness, inattention, hyperactivity, impulsivity, anxiety, and anger outbursts, the presence of tics should prompt clinicians to look for these other conditions. While randomized controlled trials provide valid evidence of efficacy for symptoms in isolation, implications for treatment of complex patients meeting criteria for multiple diagnoses is not always clear. In this review, the authors critically review factors influencing decisions whether and how to treat medically tics as well as OCD and ADHD in the presence of tics. (C) 2014 The Authors. Published by Elsevier Inc.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 50 条
  • [1] Pharmacological treatment of tic disorders and Tourette Syndrome
    Roessner, Veit
    Schoenefeld, Katja
    Buse, Judith
    Bender, Stephan
    Ehrlich, Stefan
    Muenchau, Alexander
    NEUROPHARMACOLOGY, 2013, 68 : 143 - 149
  • [2] Pharmacological treatment of Gilles de la Tourette syndrome
    Hartmann, Andreas
    Worbe, Yulia
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2013, 37 (06): : 1157 - 1161
  • [3] Pharmacological interventions in Tourette syndrome
    Benaroya-Milshtein, N.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2015, 24 : S58 - S58
  • [4] Pharmacological treatment of Tourette's syndrome: from the past to the future
    Gong, Hao
    Du, Xiangyu
    Su, Anping
    Du, Yaowu
    NEUROLOGICAL SCIENCES, 2024, 45 (03) : 941 - 962
  • [5] Pharmacological treatment of tics in Gilles de la Tourette Syndrome
    Cavanna, Andrea E.
    Nani, Andrea
    CLINICAL MANAGEMENT ISSUES, 2011, 5 (04) : 145 - 155
  • [6] The Presence of Comorbidity in Tourette Syndrome Increases the Need for Pharmacological Treatment
    Debes, Nanette M. M. M.
    Hjalgrim, Helle
    Skov, Liselotte
    JOURNAL OF CHILD NEUROLOGY, 2009, 24 (12) : 1504 - 1512
  • [7] Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options
    Rizzo, Renata
    Gulisano, Mariangela
    Cali, Paola V.
    Curatolo, Paolo
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (05) : 421 - 428
  • [8] Pharmacological treatment of Tourette’s syndrome: from the past to the future
    Hao Gong
    Xiangyu Du
    Anping Su
    Yaowu Du
    Neurological Sciences, 2024, 45 : 941 - 962
  • [9] An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms
    Lenka, Abhishek
    Jankovic, Joseph
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (10) : 1025 - 1033
  • [10] Novel Pharmacological Approaches for Tourette Syndrome
    Fletcher, Julian
    Martino, Davide
    Pringsheim, Tamara
    CURRENT DEVELOPMENTAL DISORDERS REPORTS, 2020, 7 (04) : 270 - 276